Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
O'Rourke, T.J., Brown, T.D., Havlin, K., Kuhn, J.G., Craig, J.B., Burris, H.A., Satterlee, W.G., Tarassoff, P.G., Von Hoff, D.D.
Published in European journal of cancer (1990) (1994)
Published in European journal of cancer (1990) (1994)
Get full text
Journal Article
Olanzapine: A promising “atypical” antipsychotic agent
Tran, P.V., Beasley, C.M., Tollefson, G.D., Beuzen, J.N., Holman, S.L., Sanger, T.M., Satterlee, W.G.
Published in Schizophrenia research (01.04.1995)
Published in Schizophrenia research (01.04.1995)
Get full text
Journal Article